The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine.

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.

There is common ground. Most adults favor: Preventing chronic diseases (Republicans 86%, Democrats 91%) Protecting against ...

Among other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...

A group of public health experts and scientists is mobilizing to counter vaccine misinformation from federal agencies, in an ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Today marks 100 days since President Donald Trump took office — a period for the health care world that’s been distinguished ...

Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant Sanofi’s Indian ...